About Advance Space Monitor, LLC

Advance Space Monitor, LLC (ASM) has acquired an exclusive worldwide license through NASA’s Jet Propulsion Laboratory (JPL) and the California Institute of Technology (Caltech)’s Patented Technologies Office to commercialize patents related to rapid detection of pathogens. The company will manage, produce and perform research, development and product testing utilizing this licensed technology. Currently, four subsidiary companies are being established to market and sell products to four distinct markets; First responder and military market, healthcare industry, mold remediation market, and the hospitality industry.

Our mission is to become the world’s leading provider of secure, reliable, and low cost surface and water spore detection products. In doing so, ASM will fill a void that exists today for products that provide rapid and accurate endospore detection. Current competitive products offer an expensive and lengthy, 72 hours, testing process, or are too labor intensive to be practical. ASM’s products are being designed to be competitively priced, easy to use and provide a rapid detection analysis time of 4 minutes, while maintaining a 99% accuracy rate.

In the United States alone, the incidence of hospital-acquired infections is 2 million cases per year, which results in over 90,000 deaths. This has an annual economic impact of $6.7 billion dollars in added cost to the U.S. healthcare system.

In 2005, there were over 11,000 terrorist attacks carried out around the world. This does not even account for the potential attacks that were planned, but stopped by law enforcement. Bio-Terrorism is a real threat that can cause, at the very least, public chaos, sickness and death.

According to a 2002 study done by the National Institute of Health and Medical Research in Paris, 1 in 5 persons with Asthma has severe attacks in the presence of mold. Infections, bio-terrorism and mold have one thing in common; they are caused by spores of living organisms. The previous technology to ensure proper hygiene was to perform a protein based test. That test did not detect the real problem: Spores! Technology developed by NASA in conjunction with Caltech, which was to ensure that space travelers did not risk contamination to the environment, is the same technology ASM uses to detect and destroy infectious water or surface-borne spores in hospitals, homes and on the battlefield.

An expensive process that used to take 72 hours can be reduced to just 4 minutes with extreme accuracy, at low cost. This changes everything. Hospitals can now be assured that the very room from where an infected person has just been released is appropriately disinfected and ready for a new patient, without fear of infection or unintentional suffering. Extra hospital cost associated with hospital-acquired infections will go down and hospital beds can be fully utilized to treat more patients. Within minutes, law enforcement can now determine whether or not the presence of a white powder in a public place is a threat. This will reduce chaos and the strain on law enforcement resources, when threats are determined not to be real, yet, taking every threat seriously. Mold can be detected and removed safely in homes and public buildings before the effects of mold-related illnesses, such as severe asthma, pose public health issues.

The management team has extensive experience in the design, marketing and selling of medical and high-tech devises. The team includes:

Dale F. Tommer, Jr., Manager and Chief Operating Officer, is a co-founder of ASM. He brings over 36 years of successful technical and management experience to the company, specifically as Program Manager at GTE and Lincoln Laboratories. In 1994, Mr. Tommer founded Advance Technology Inc, an original equipment manufacturer (OEM), to supply electronic components to American Power Conversion, Heat Transfer and Techsave corporations.

Klas D. Romberg, MD, Partner, co-founder ASM, LLC, is a practicing physician in the field of radiology with over 30 years of experience including the management of a large radiology department in a community hospital setting. He is also a co-founder of ASM. He is presently an active member of the medical staff and the Infection Control Committee at Brockton Hospital in Massachusetts.

Monsour H. Hanoud, co-founder of ASM, LLC is an entrepreneur and owner/CEO of USRV, Inc. and USRV Leasing.

Richard L. Tuttle, MBA is the Chief Financial Officer. Mr. Tuttle brings 15 years of financial management experience to the position. He has held the top financial leadership position at Eikos LLC, a Department of Defense and NASA contractor, and Korsch America Inc, a distributor of pharmaceutical manufacturing equipment in North and South America. Prior positions include manufacturing/financial analyst for Johnson & Johnson Professional Inc. and Teradyne, Inc. He is a member of the Institute of Management Accountants, and holds business and finance degrees from the University of Maine and Clark University.